BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20630410)

  • 1. Outcomes associated with anemia in patients with heart failure.
    Salisbury AC; Kosiborod M
    Heart Fail Clin; 2010 Jul; 6(3):359-72. PubMed ID: 20630410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of anemia in heart failure.
    Spence RK
    Heart Fail Clin; 2010 Jul; 6(3):373-83. PubMed ID: 20630411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mediators of anemia in chronic heart failure.
    Le Jemtel TH; Arain S
    Heart Fail Clin; 2010 Jul; 6(3):289-93. PubMed ID: 20630403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
    Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
    Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in management of anemia in heart failure.
    Agarwal AK; Katz SD
    Heart Fail Clin; 2010 Jul; 6(3):385-95. PubMed ID: 20630412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of anemia in heart failure.
    Stamos TD; Silver MA
    Curr Opin Cardiol; 2010 Mar; 25(2):148-54. PubMed ID: 19996965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin in heart failure.
    Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
    Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with iron of patients with heart failure with and without anemia.
    Jelani QU; Attanasio P; Katz SD; Anker SD
    Heart Fail Clin; 2010 Jul; 6(3):305-12. PubMed ID: 20630405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia in chronic heart failure.
    Drakos SG; Anastasiou-Nana MI; Malliaras KG; Nanas JN
    Congest Heart Fail; 2009; 15(2):87-92. PubMed ID: 19379455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
    Iaina A; Silverberg DS; Wexler D
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron alone is equally effective with the combination of iron and erythropoietin for the treatment of iron-deficiency anemia in advanced heart failure.
    Terrovitis JV; Kaldara E; Ntalianis A; Sventzouri S; Kapelios C; Barbarousi D; Matsouka C; Nanas JN
    J Am Coll Cardiol; 2012 Nov; 60(21):2255-6. PubMed ID: 23103041
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.
    Zilberman M; Silverberg DS; Bits I; Steinbruch S; Wexler D; Sheps D; Schwartz D; Oksenberg A
    Am Heart J; 2007 Nov; 154(5):870-6. PubMed ID: 17967592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options.
    Tang YD; Katz SD
    Circulation; 2006 May; 113(20):2454-61. PubMed ID: 16717164
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence, prognostic importance and therapeutic implications of anemia in heart failure.
    Mishra TK; Mishra SK; Mohanty NK; Rath PK
    Indian Heart J; 2005; 57(6):670-4. PubMed ID: 16521636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic.
    Ezekowitz JA; McAlister FA; Armstrong PW
    Can J Cardiol; 2005 Feb; 21(2):165-71. PubMed ID: 15729416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project.
    Kosiborod M; Curtis JP; Wang Y; Smith GL; Masoudi FA; Foody JM; Havranek EP; Krumholz HM
    Arch Intern Med; 2005 Oct; 165(19):2237-44. PubMed ID: 16246989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.
    Beck-da-Silva L; Rohde LE; Pereira-Barretto AC; de Albuquerque D; Bocchi E; Vilas-Boas F; Moura LZ; Montera MW; Rassi S; Clausell N
    J Card Fail; 2007 Feb; 13(1):14-7. PubMed ID: 17338998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hidden woes of anemia and sleep-disordered breathing in heart failure: killing two birds with one stone.
    Young JB
    Am Heart J; 2007 Nov; 154(5):805-7. PubMed ID: 17967582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.